TRxADE HEALTH Inc. (MEDS)
NASDAQ: MEDS
· Real-Time Price · USD
7.59
0.33 (4.55%)
At close: Sep 20, 2024, 10:00 PM
TRxADE HEALTH Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 128.2K | 146.9K | 136.64K | 2.44M | 4.43M | 6.66M | 8.91M | 9.09M | 9.43M | 10.46M | 11.45M | 11.31M | 11.46M | 10.08M | 9.89M | 9.5M | 13.28M | 17.97M |
Cost of Revenue | 112.52K | 131.92K | 130.64K | 4.69M | 4.98M | 5.57M | 6.25M | 2.64M | 3.28M | 4.78M | 6M | 6.16M | 6.43M | 5.38M | 5.14M | 5.86M | 8.99M | 12.52M |
Gross Profit | 15.68K | 14.98K | 6K | -2.25M | -553.02K | 1.09M | 2.66M | 6.45M | 6.15M | 5.67M | 5.45M | 5.15M | 5.03M | 4.7M | 4.75M | 3.64M | 4.29M | 5.45M |
Operating Income | -21.57M | -16.35M | -18.78M | -16.68M | -14.03M | -12.88M | -7.73M | -1.82M | -1.38M | -2.14M | -2.76M | -3.26M | -4.15M | -5.62M | -5.29M | -6.82M | -5.37M | -3.34M |
Interest Income | 119.97K | 97.86K | 135.34K | 133.4K | 103.95K | 62.92K | 4.2K | 16.79K | 25.19K | 25.19K | 20.99K | 8.4K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 8.08M | 13.17M | 9.6M | -23.16M | -20.15M | -20.5M | -14.19M | -3.78M | -4.13M | -3.27M | -3.91M | -3.39M | -4.16M | -5.63M | -5.32M | -6.84M | -5.4M | -3.37M |
Net Income | -20.31M | -15.42M | -20.79M | -25.17M | -25.51M | -25.66M | -17.28M | -7.33M | -4.31M | -3.42M | -4.31M | -3.33M | -4.13M | -5.62M | -5.32M | -6.84M | -5.4M | -3.37M |
Selling & General & Admin | 6.15M | 4.42M | 8.14M | 12.56M | 12.61M | 12.75M | 8.94M | 6.86M | 6.23M | 6.66M | 7.05M | 7.57M | 8.63M | 8.84M | 8.81M | 8.5M | 7.71M | 8.06M |
Research & Development | 3.6M | 2.76M | 2.24M | 1.67M | 831K | 1.27M | 1.45M | 1.4M | 1.29M | 1.15M | 1.16M | 2.21M | 1.91M | 1.61M | 1.37M | 662.73K | 662.73K | 662.73K |
Other Expenses | 6.57M | 5.39M | 4.17M | 157.47K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.62M | 1.62M | 1.62M | 1.62M | 3.25M | 3.25M | 3.25M |
Operating Expenses | 16.31M | 12.65M | 14.58M | 14.43M | 13.48M | 13.97M | 10.39M | 8.27M | 7.52M | 7.81M | 8.21M | 8.41M | 9.18M | 9.09M | 8.81M | 8.5M | 7.71M | 8.06M |
Interest Expense | -2.76M | -2.1M | -1.34M | 1.02M | 1.06M | 1.23M | 1.2M | 690.48K | 568.81K | 397.23K | 336.21K | 142.64K | 18.16K | 17.69K | 23.59K | 28.3K | 30.11K | 28.73K |
Selling & Marketing Expenses | -607.77K | -607.77K | n/a | 607.77K | 607.77K | 607.77K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 11.27M | 12.78M | 14.71M | 19.12M | 18.46M | 19.54M | 16.64M | 10.9M | 10.81M | 12.59M | 14.2M | 14.57M | 15.61M | 14.47M | 13.96M | 14.36M | 16.7M | 20.59M |
Income Tax Expense | -1.27M | -1.27M | 534.4K | 1.8M | 5.41M | 5.59M | 3.52M | 3.99M | 356.04K | 175.31K | 438.62K | -23.72K | 7.64K | 16.33K | 16.33K | 21.04K | 15.41K | 6.72K |
Shares Outstanding (Basic) | 14.14M | 4.71M | 3.38M | 2.37M | 1.41M | 1.04M | 931.88K | 771.19K | 681.2K | 670.72K | 618.81K | 549.98K | 545.4K | 545.21K | 544.46K | 544.24K | 541.48K | 539.55K |
Shares Outstanding (Diluted) | 14.14M | 4.71M | 3.65M | 2.37M | 1.41M | 1.04M | 931.88K | 771.19K | 681.2K | 670.72K | 618.81K | 549.98K | 545.4K | 545.21K | 544.46K | 544.24K | 541.48K | 539.55K |
EPS (Basic) | 11.00 | 10.18 | 2.69 | -23.35 | -26.58 | -28.18 | -20.13 | -10.42 | -6.76 | -5.85 | -7.51 | -6.09 | -7.57 | -10.34 | -9.8 | -12.64 | -9.99 | -6.3 |
EPS (Diluted) | 10.79 | 9.97 | 2.48 | -23.35 | -26.58 | -28.18 | -20.13 | -10.42 | -6.76 | -5.85 | -7.51 | -6.09 | -7.57 | -10.34 | -9.8 | -12.64 | -9.99 | -6.3 |
EBITDA | 6.85M | 11.95M | 9.52M | -15.53M | -12.76M | -13.11M | -7.91M | -3.5M | -3.67M | -2.76M | -3.38M | -3.07M | -3.98M | -5.45M | -5.15M | -6.67M | -5.25M | -3.23M |
EBIT | 8.16M | 6.54M | n/a | -22.14M | -19.01M | -19.44M | -13.97M | -4.07M | -4.44M | -3.5M | -3.39M | -3.06M | -4.15M | -5.61M | -5.29M | -6.82M | -5.37M | -3.34M |
Depreciation & Amortization | 5.97K | 14.33K | 22.64K | 754.75K | 1.06M | 1.11M | 1.15M | 500.47K | 236.29K | 219.27K | 225.25K | 195.59K | 166.06K | 163.78K | 138.91K | 140.86K | 119.87K | 111.06K |